NCT00687999View on ClinicalTrials.gov

NIDDM and IR in Combination Therapy for CHC

NACompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Chronic Hepatitis CInsulin Resistance
Interventions
DRUG

pegylated interferon alpha and ribavirin

standard pegylated interferon alpha and ribavirin

Trial Locations (1)

807

Kaohsiung Medical University Hospital, Kaohsiung City

All Listed Sponsors
collaborator

National Science and Technology Council, Taiwan

OTHER_GOV

lead

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER

NCT00687999 - NIDDM and IR in Combination Therapy for CHC | Biotech Hunter | Biotech Hunter